Electrophysiologie cérébrale, épilepsie, sommeil, Hôpital Pierre Paul Riquet
Toulouse, Oui, 31000, France
NCT Number: NCT07796984
As part of the clinical management of certain severe, drug-resistant forms of epilepsy, it is necessary to implant electrodes in the brain to identify the epileptic network prior to potential neurosurgical resection of the source zones. This standardized procedure, known as Stereo-Electroencephalography (SEEG), was developed in France in the 1960s. The electrodes remain implanted for several days-typically two weeks-while awaiting spontaneous epileptic seizures. During this period, the patient remains hospitalized, and their electroencephalographic activity is recorded around the clock.
Patients can be asked to perform cognitive tasks (such as tasks involving memory, attention, vision, language, and decision-making) while awake or asleep; the results can then be correlated with the intracerebral electroencephalographic activity recorded simultaneously as part of their clinical care. This approach makes it possible to capture the electrophysiological signatures of specific cognitive processes, thereby enabling researchers to: 1) create a brain map of electrophysiological signatures, 2) improve standard models of cognitive function, and 3) study the dysfunction of these processes in epilepsy.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Observational
Toulouse, Oui, 31000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During their hospitalization for SEEG, patients will perform cognitive tasks to assess memory, vision, attention, language, and decision-making.
Time frame: 3 weeks after the inclusion
Correlation of performance on a task involving a neurocognitive process with characteristics of brain activity recorded during the task (electrophysiological signature) using intracranial stereo-electroencephalography (SEEG) electrodes.
Time frame: 3 weeks after the inclusion
Significant impact of the patient's epilepsy on the normal electrophysiological signature expected during certain cognitive processes.
Time frame: 3 weeks after the inclusion
Identification of a dysfunctional brain region in an epileptic patient if the electrophysiological signature differs significantly from that expected based on the atlas.
Contact information is provided by the study sponsor or research team.
University Hospital, Toulouse
Other
Study of the Intracerebral Electrophysiological Signature of Cognitive Processes and Functional Mapping in Patients With Drug-resistant Epilepsy
Acronym: ACTELIN 2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07520955
Brain Diseases, Central Nervous System Diseases
Madison, Wisconsin, United States
View Trial DetailsNCT07451093
Brain Diseases, Central Nervous System Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT07790224
Brain Diseases, Central Nervous System Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07768618
Behavior, Behavioral Symptoms
Atlanta, Georgia, United States
View Trial Details